Varicella-zoster virus
PreclinicalBiologic
AstraZenecaVaricella-zoster virus is one of 12 biologic programs targeting Chickenpox. It is currently in Preclinical.
1
Indications
2
Total Trials
0
Active Trials
11
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
11 competitors in Chickenpox
#DrugCompanyPhaseTrials
1Zovirax
BBp Consulting, Inc
Approved
Hepatitis a Vaccine
SanofiPhase 3
Investigational Cancer Drug
GSKPhase 3
Marketed Paracetamol
GSKPhase 3
Vaxneuvance
GSKPhase 3
PCV 20
GSKPhase 3
MMR-Vaccine
GSKPhase 3
Candidate Varicella Vaccine
GSKPhase 3
YF-Vax
SanofiPreclinical
Valtrex
GGlaxo Dba Glaxosmithkline
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Varicella-zoster virus. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company